Test Code DT PMP Drug Test Urine Pain Management Panel
Useful For
Detection of drugs of abuse in urine. Used to monitor compliance for pain management patients.
Patient Preparation
No special patient preparation required
Collection Method
Random urine
Minimum Volume
5 mL
Container
Sterile Cup
Preferred Specimen
30 mL freshly voided urine
Acceptable Specimens
5 mL freshly voided urine
Reference or Target Ranges
Screening Cutoff Levels Drug Test Urine Pain Management
Panel * EIA pain management screen performed on Olympus AU680 |
|
---|---|
Drug | Screening Cutoff |
6-Acetylmorphine | 10 ng/mL |
Acetaminophen | 25 ng/mL |
Amphetamines | 500 ng/mL |
Barbiturates | 300 ng/mL |
Benzodiazepines | 300 ng/mL |
Buprenorphine | 5 ng/mL |
Cannabinoids (THC) | 50 ng/mL |
Carisoprodol | 100 ng/mL |
Cocaine | 150 ng/mL |
Ethanol | 20 mg/dL |
Fentanyl | 10 ng/mL |
Meperidine | 100 ng/mL |
Methadone | 300 ng/mL |
Opiates | 300 ng/mL |
Oxycodone | 100 ng/mL |
Phencyclidine (PCP) | 25 ng/mL |
Salicylate | 5 ng/mL |
Tramadol | 100 ng/mL |
Confirmation Cutoff Levels Drug Test Urine Pain Management * Patients that screen positive for any of the above will be confirmed via solid phase extraction and GCMS analysis. |
|
Drug | Confirmation Cutoff |
Benzodiazepines | |
7-Aminoclonazepam | 100 ng/mL |
Lorazepam | 100 ng/mL |
Nordiazepam | 100 ng/mL |
OH-Alprazolam | 100 ng/mL |
Oxazepam | 100 ng/mL |
Temazepam | 100 ng/mL |
Opiates | |
Codeine | 300 ng/mL |
Hydrocodone | 300 ng/mL |
Hydromorphone | 300 ng/mL |
Morphine | 300 ng/mL |
Oxycodone | 300 ng/mL |
Oxymorphone | 300 ng/mL |
Amphetamines | |
Amphetamine | 250 ng/mL |
Methamphetamine | 250 ng/mL |
MDA (Methylenedioxyamphetamine) | 250 ng/mL |
MDMA (Methylenedioxymethamphetamine) | 250 ng/mL |
MDEA (Methylenedioxyethylamphetamine) | 250 ng/mL |
Barbiturates | |
Amobarbital | 100 ng/mL |
Butalbital | 100 ng/mL |
Pentobarbital | 100 ng/mL |
Phenobarbital | 100 ng/mL |
Secobarbital | 100 ng/mL |
Drug Test Urine Comprehensive Limit of Quantitation (LOQ) * Drugs included in pain management drug test performed by GCMS analysis |
|
Drug | LOQ |
Amphetamine | 125 ng/mL |
Alprazolam | 20 ng/mL |
Butalbital | 100 ng/mL |
Buprenorphine | 50 ng/mL |
Carisoprodol | 100 ng/mL |
Cocaine | 20 ng/mL |
Codeine | 60 ng/mL |
Clonazepam | 20 ng/mL |
Fentanyl | 10 ng/mL |
Hydrocodone | 60 ng/mL |
Hydromorphone | 60 ng/mL |
Methamphetamine | 125 ng/mL |
Meperidine | 100 ng/mL |
Methadone/EDDP | 100 ng/mL |
Morphine | 60 ng/mL |
Nordiazepam | 20 ng/mL |
Oxycodone | 60 ng/mL |
Oxymorphone | 60 ng/mL |
Oxazepam | 20 ng/mL |
Phenobarbital | 100 ng/mL |
Phencyclidine | 20 ng/mL |
Temazepam | 20 ng/mL |
Tramadol | 100 ng/mL |
The following drugs will have cutoff concentrations that vary
depending upon which class members and/or metabolites are present.
Some drugs are only detectable at toxic concentrations as the
detection limits vary depending on the drug being identified:
6-Acetylmorphine, Acetaminophen, Amitriptyline, Aripiprazole,
Bupropion, Caffeine, Carbamazepine, Chlorpheniramine, Gabapentin,
Hydroxyzine, Ibuprofen, Imipramine/Desipramine, Ketamine,
Lamotrigine, Levetiracetam, Lidocaine, Meprobamate/Carisoprodol,
Methylphenidate, Metoprolol, Mirtazapine, Naproxen,
Nicotine/Cotinine, Nortriptyline, Oxcarbazepine, Paroxetine,
Phentermine, Phenytoin, Quetiapine, Quinine and/or Quinidine,
Salicylate, Sertraline, Topiramate, Valproic Acid, Venlafaxine
Reportable Units
See table
Critical Value
Not defined for this assay
Reasons for Rejection
Hemolysis Threshold | N/A |
Icterus Threshold | N/A |
Lipemia Threshold | N/A |
Other | QNS, contaminated, improperly labeled, improper specimen type |
Specimen Stability
Ambient | 7 days |
Refrigerated (4°C to 8°C) | 14 days |
Frozen(-40°C to 0°C) | 365 days |
Performance Information
Days and Time Performed | Monday – Friday 730 AM – 430 PM |
Expected Turn Around Time | 72 hours |
Stat Availability | No |
Performing Bench | Toxicology |
Methodology/Method Description | Screen: Olympus AU680 – EIA Confirmation: Liquid/Liquid extraction, Solid phase extraction, Gas chromatography mass spectrometry |
Additional Information/Important Notes
Patients that fall below the cutoff will be reported as negative.
CPT Codes
80307, G0483
Panel Components
Screen:
- 6-Acetylmorphine
- Acetaminophen
- Amphetamines
- Barbiturates
- Benzodiazepines
- Buprenorphine
- Cannabinoids (THC)
- Carisoprodol
- Cocaine
- Ethanol
- Fentanyl
- Meperidine
- Methadone
- Opiates
- Oxycodone
- Phencyclidine (PCP)
- Salicylate
- Tramadol